HOME :: EVENTS :: READING ROOM :: MEDCOMMS ORGANIZATIONS :: INDEPENDENTS :: SERVICES :: JOB ADS

Adrian Brown Alan Morris Alice Moore Amanda Halliday Amy Hargreaves Ben Thomas Bev Hicks Bill Wolvey Cate Scott Christopher Pym Claire Lea Claire Scarborough Elaine Ferguson Emma Kenny Fiona Matheson Gill Sperrin Gwen Napolitano Jessica Beishon Kate Carpenter Laila Lynch Laura McGovern Liz Baker Liz McNeil Grist Liz Reader Louise Richards Marion Barnett Mary Berrington Matthew Konneh Max Brady Nicole CollingwooD Paul Tregouet Peter Llewellyn Roseanne Wilkinson Siobhan Burn Stewart Jones Sue Neville Susan Macdonald

This initiative is currently being led by Peter Llewellyn of NetworkPharma. To learn more about Peter Llewellyn and link back to other relevant connections in medical communications see his profile on LinkedIn.

Eugene Pozniak of Siyemi Learning, explained how in the absence of a single, overarching regulatory body for CME activity across the region, individual countries are at varying stages of implementation. As such, the accreditation process throughout the continent is a splintered affair, governed by four different types of regulatory authority: National Accreditation Authorities, the European Accreditation Council for CME, European Specialty Accreditation Boards and Accredited Providers. The attitude to CME differs from country to country. Across Europe, each individual autonomous healthcare system has different requirements and expectations of its doctors. In some countries, CME is mandatory, while in others, it is voluntary. In some, it is neither understood nor recognised. However, even in areas where CME is a legal obligation, enforcing compliance remains a challenge. Incentives and punitive measures, some seemingly Draconian, have been introduced to encourage and enforce uptake, but so far a successful method to police the system has yet to emerge. Despite such a confusing environment, CME-accredited education is regarded as being important. The axiom that CME is ‘education for doctors, written by doctors, presented by doctors’ dictates that there should be no direct industry involvement in specific CME programmes. However, the corporate goodwill derived from being associated with high-quality educational activity, and the benefits of increased therapeutic awareness within the prescribing community, make CME a vital consideration for industry. Whilst it is clear that companies cannot stipulate, manipulate or influence CME content, it is equally clear that companies who fail to support it may somehow be relinquishing an opportunity for competitive advantage. Eugene has set up some learning modules on his web site which will provide further useful insights into this important topic. To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.

This web site and associated activities are being managed by NetworkPharma Ltd, 89 Oxford Road, Oxford, OX2 9PD, UK
Telephone +44 (0) 1865 865943 Email: support@networkpharma.com